Aptuit, a US supplier of drug discovery and development services, has appointed two new members to its Executive Leadership team.
Kurt Dinkelacker has been named Executive Vice President and Chief Financial Officer and Kevin Duffield has been promoted to Vice President, Sales and Business Development.
Dinkelacker reports directly to Stuart Needleman, Aptuit’s President and COO. Previously, he was an Executive Vice President and CFO at Retrievex. Before that, he held leadership positions at Financing Alternatives, TeleSpectrum Worldwide and IKON Office Solutions.
Duffield takes on new responsibilities as Aptuit’s Vice President of Sales and Business Development. He will be handling global sales and marketing, also reporting directly to Needleman. He has more than 25 years of experience in pharmaceutical contract manufacturing services. He has held several leadership positions in sales, business development, and operations of cGMP development and manufacturing facilities. Before he joined Aptuit, he worked for Eastman Fine Chemicals, ChiRex and NovaSep.